Suppr超能文献

TLR4基因启动子rs1927914变异与中国人群食管鳞状细胞癌易感性相关。

TLR4 promoter rs1927914 variant contributes to the susceptibility of esophageal squamous cell carcinoma in the Chinese population.

作者信息

Li Jiaying, Wu Hongjiao, Gao Hui, Kou Ruihuan, Xie Yuning, Zhang Zhi, Zhang Xuemei

机构信息

School of Public Health, North China University of Science and Technology, Tangshan, China.

College of Life Science, North China University of Science and Technology, Tangshan, China.

出版信息

PeerJ. 2021 Feb 1;9:e10754. doi: 10.7717/peerj.10754. eCollection 2021.

Abstract

BACKGROUND

Toll-like receptor 4 (TLR4), as a key regulator of both innate and acquired immunity, has been linked with the development of various cancers, including esophageal cancer. This study aims to analyze the association of potential functional genetic polymorphisms in TLR4 with the risk of esophageal cancer.

METHODS

This case-control study involved in 480 ESCC patients and 480 health controls. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to genotype TLR4 rs1927914 polymorphism. Taqman probe method was used to determine the genotypes of TLR4 rs11536891 and rs7873784 variants. The relationship between TLR4 genetic variation and ESCC risk was analyzed by Logistic regression model by calculating the odds ratio () and 95% confidence interval (95% CI).

RESULTS

Compared with TLR4 rs1927914 AA genotype carriers, GG carriers had a lower ESCC risk (OR = 0.59, 95% CI [0.38-0.93], = 0.023). Stratification analysis by age showed that TLR4 rs1927914 GG could affect the risk of ESCC in elderly people (OR = 0.59, 95% CI [0.36-0.97]). Smoking stratification analysis indicated that rs1927914 GG carriers were related to ESCC susceptibility among non-smokers ( = 0.36, 95% CI [0.18-0.73]). Dual luciferase reporter assay suggested that rs1927914 G-containing TLR4 promoter displayed a 1.76-fold higher luciferase activity than rs1927914 A-containing counterpart in KYSE30 cells. Electrophoretic mobility shift assay (EMSA) showed the KYSE30 cell nuclear extract was able to bind the probe with rs1927914 G allele and this DNA-protein interaction could be eliminated by competition assays with unlabeled rs1927914 G probe, which indicating that the binding is sequence-specific. Our results also showed that TLR4 rs7873784 (G>C) and rs11536891 (T>C) conformed to complete genetic linkage. The genotype distributions of TLR4 rs11536891 variant among ESCC patients and normal controls have no statistical significance.

CONCLUSION

The TLR4 rs1927914 variant contributes to the ESCC risk by effecting the promoter activity.

摘要

背景

Toll样受体4(TLR4)作为先天性和获得性免疫的关键调节因子,与包括食管癌在内的多种癌症的发生发展有关。本研究旨在分析TLR4潜在功能性基因多态性与食管癌风险的关联。

方法

本病例对照研究纳入480例食管癌患者和480例健康对照。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对TLR4 rs1927914多态性进行基因分型。采用Taqman探针法确定TLR4 rs11536891和rs7873784变异的基因型。通过计算比值比(OR)和95%置信区间(95%CI),采用Logistic回归模型分析TLR4基因变异与食管癌风险的关系。

结果

与TLR4 rs1927914 AA基因型携带者相比,GG携带者的食管癌风险较低(OR = 0.59,95%CI [0.38 - 0.93],P = 0.023)。按年龄分层分析显示,TLR4 rs1927914 GG可影响老年人的食管癌风险(OR = 0.59,95%CI [0.36 - 0.97])。吸烟分层分析表明,rs1927914 GG携带者与非吸烟者的食管癌易感性有关(OR = 0.36,95%CI [0.18 - 0.73])。双荧光素酶报告基因检测表明,在KYSE30细胞中,含rs1927914 G的TLR4启动子的荧光素酶活性比含rs1927914 A的对应物高1.76倍。电泳迁移率变动分析(EMSA)显示,KYSE30细胞核提取物能够与含rs1927914 G等位基因的探针结合,并且这种DNA-蛋白质相互作用可以通过与未标记的rs1927914 G探针的竞争试验消除,这表明这种结合是序列特异性的。我们的结果还表明,TLR4 rs7873784(G>C)和rs11536891(T>C)符合完全遗传连锁。TLR4 rs11536891变异在食管癌患者和正常对照中的基因型分布无统计学意义。

结论

TLR4 rs1927914变异通过影响启动子活性影响食管癌风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f39/7860108/8e16e7a26f3a/peerj-09-10754-g001.jpg

相似文献

2
Genetic association and functional implications of TLR4 rs1927914 polymorphism on colon cancer risk.
BMC Cancer. 2024 Jul 18;24(1):858. doi: 10.1186/s12885-024-12604-z.
3
Genetic variants in the regulation region of TLR4 reduce the gastric cancer susceptibility.
Gene. 2021 Jan 30;767:145181. doi: 10.1016/j.gene.2020.145181. Epub 2020 Sep 30.
4
TLR4 rs1927914 polymorphism contributes to serum TLR4 levels in patients with aortic aneurysm.
Exp Mol Pathol. 2021 Apr;119:104609. doi: 10.1016/j.yexmp.2021.104609. Epub 2021 Jan 29.
5
Impact of Genetic Variation in 3'UTR on NSCLC Genetic Susceptibility.
J Oncol. 2020 Apr 9;2020:7593143. doi: 10.1155/2020/7593143. eCollection 2020.
6
TLR4 regulatory region variants reduce the susceptibility of small-cell lung cancer in Chinese population.
Eur J Cancer Prev. 2022 Jul 1;31(4):363-368. doi: 10.1097/CEJ.0000000000000737. Epub 2022 May 13.
7
Associations of TLR4 gene polymorphisms with the risk of age-related macular degeneration in a Chinese Han population.
Medicine (Baltimore). 2019 May;98(19):e15583. doi: 10.1097/MD.0000000000015583.
9
Genetic variant in CASP3 affects promoter activity and risk of esophageal squamous cell carcinoma.
Cancer Sci. 2012 Mar;103(3):555-60. doi: 10.1111/j.1349-7006.2011.02173.x. Epub 2012 Jan 9.
10
Interaction between toll-like receptor 4 (TLR4) gene and alcohol drinking on Parkinson's disease risk in Chinese Han population.
J Clin Neurosci. 2019 Apr;62:128-132. doi: 10.1016/j.jocn.2018.12.002. Epub 2018 Dec 26.

引用本文的文献

本文引用的文献

2
3
Impact of Genetic Variation in 3'UTR on NSCLC Genetic Susceptibility.
J Oncol. 2020 Apr 9;2020:7593143. doi: 10.1155/2020/7593143. eCollection 2020.
4
High TLR4 expression predicts a poor prognosis after esophagectomy for advanced thoracic esophageal squamous cell carcinoma.
Esophagus. 2020 Oct;17(4):408-416. doi: 10.1007/s10388-020-00732-x. Epub 2020 Mar 13.
6
TLR4 expression correlated with PD-L1 expression indicates a poor prognosis in patients with peripheral T-cell lymphomas.
Cancer Manag Res. 2019 May 23;11:4743-4756. doi: 10.2147/CMAR.S203156. eCollection 2019.
7
Polymorphisms of , are associated with prognosis of gastric cancer in a Chinese population.
Cancer Cell Int. 2018 Nov 20;18:191. doi: 10.1186/s12935-018-0682-0. eCollection 2018.
8
TLR4 Polymorphisms and Expression in Solid Cancers.
Mol Diagn Ther. 2018 Dec;22(6):683-702. doi: 10.1007/s40291-018-0361-9.
9
TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings.
Mol Pharm. 2018 Nov 5;15(11):4777-4800. doi: 10.1021/acs.molpharmaceut.8b00691. Epub 2018 Oct 3.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验